Ricevi le ultime notizie sulle azioni Arcus Biosciences con aggiornamenti su tendenze di mercato, dati finanziari e analisi di Benzinga. Rimani informato sulle performance di RCUS

Ultime notizie per

ARCUS BIOSCIENCES INC

Arcus Biosciences

Arcus Biosciences Inc is a clinical-stage biopharmaceutical company. It develops immunotherapies for the treatment of cancer. The company focuses on an ATP-adenosine pathway, which is a key driver of immunosuppression in the tumor microenvironment to create and optimize differentiated small-molecule immuno-oncology product candidates. Its product pipeline includes Domvanalimab, Etrumadenant, AB598, Casdatifan among others. Arcus conducts clinical trials for different types of cancers such as Lung, Colorectal, Pancreatic, and others. The company operates through a single segment which is the business of developing and commercializing immunotherapies.

Arcus BioSciences

Long Ideas

News

Markets

Media

Trading Ideas

RCUS

Il celebre presentatore televisivo del popolare show finanziario ha svelato la sua scommessa principale nel settore energetico in crescita.

Jim Cramer punta sul nucleare: ecco chi consiglia di acquistare

Arcus Biosciences Inc

Press Releases

Arcus Biosciences Announces New Employment Inducement Grants

Arcus Biosciences' Quemliclustat Receives Orphan Drug Designation for Pancreatic Cancer

Arcus Biosciences Reports Second-Quarter 2025 Financial Results and Provides a Pipeline Update

Arcus Biosciences to Participate in Three Upcoming Investor Conferences

Arcus Biosciences to Host Investor Event to Highlight its Late-Stage Casdatifan Program and Next Wave of Programs Focused on Inflammation

Ardelyx

Aurinia Pharmaceuticals Inc - Common Shares

Aurinia Pharmaceuticals

BioCryst Pharmaceuticals, Inc. - Common Stock

BioCryst Pharma

Biohaven

Celldex Therapeutics, Inc. - Common Stock

Celldex Therapeutics

CureVac

Dianthus Therapeutics, Inc. - Common Stock

Dianthus Therapeutics

Dynavax Technologies Corporation - Common Stock

Dynavax Technologies

Dyne Therapeutics

Immatics

Janux Therapeutics

MannKind

Anbio Biotechnology - Class A Ordinary Shares

Anbio Biotechnology

Novavax

Oric Pharmaceuticals, Inc. - Common Stock

ORIC Pharmaceuticals

Precigen

Praxis Precision Medicines, Inc. - Common Stock

Praxis Precision Medicine

Sionna Therapeutics

Syndax Pharmaceuticals, Inc. - Common Stock

Syndax Pharmaceuticals

Stoke Therapeutics

Tourmaline Bio

Twist Bioscience Corporation - Common Stock

Twist Bioscience

Vericel

Viridian Therapeutics, Inc. - Common Stock

Comments

Arcus Biosciences Notizie sulle azioni

Notizie

Ultime notizie per

Le persone guardano anche

Notizie

PARTNER/COLLABORATORE

BENZINGA NEL MONDO